There is a Mary Ann Liebert at Mary Ann Liebert, Inc. and that makes a difference.


Mar 25 - Mar 29, 2018
iPSCs: A Decade of Progress and Beyond
Olympic Valley, CA

The breakthrough discovery of iPSCs has transformed our prospects for regenerative medicine. The use of disease-specific iPSCs provides great hope for developing surrogate models of human diseases, platforms for drug discovery, and stem cell-based cell replacement therapies. Cutting-edge iPSC technologies, including small molecule-induced reprogramming, efficient lineage-specific differentiation, targeted gene editing, and comprehensive disease modeling will be highlighted in this symposium.

Stem Cells and Development is globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings. With a focus on stem cells of all tissue types and their potential therapeutic applications, the Journal provides clinical, basic, and translational scientists with cutting-edge research and findings.

Pick up additional information on this essential resource at iPSCs.